Market News AIOpen the app

ZVRA stock news · Zevra Therapeutics

Stories about Zevra Therapeutics (ZVRA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ZVRA

Follow Zevra Therapeutics (ZVRA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ZVRA
Free on the App Store and Google Play, or on the web.
  1. Nov 3, 2026, 6:01 PM ET · Market

    Zevra Therapeutics shared its Q3 2026 results, showing a 45% jump in revenue thanks to U.S. sales of myplifa.

    Good for ZVRA

    Zevra reported Q3 revenue of $37.8 million, up 45%, including $34 million from U.S. myplifa sales. Sales growth and cash support a favorable reading.